{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:55:40Z","timestamp":1781502940871,"version":"3.54.1"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ED2306"],"award-info":[{"award-number":["01ED2306"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["211696"],"award-info":[{"award-number":["211696"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014912","name":"Rhineland-Palatinate Natural Products Research Centre, Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.biopha.2025.117969","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:41:39Z","timestamp":1741668099000},"page":"117969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Influence of Ibuprofen on glycerophospholipids and sphingolipids in context of Alzheimer\u00b4s Disease"],"prefix":"10.1016","volume":"185","author":[{"given":"Juliane","family":"Radermacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2567-6991","authenticated-orcid":false,"given":"Vincent Konrad Johannes","family":"Erhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2695-4525","authenticated-orcid":false,"given":"Oliver","family":"Walzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie Christiane","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin Nicolas","family":"Kuppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill Sven Ren\u00e9","family":"Z\u00fcgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Andrea","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike Sabine","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-6506","authenticated-orcid":false,"given":"Marcus Otto Walter","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117969_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10787-009-0016-x","article-title":"Ibuprofen: pharmacology, efficacy and safety","volume":"17","author":"Rainsford","year":"2009","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2025.117969_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.117969_bib3","first-page":"1371","article-title":"NSAID prescribing precautions","volume":"80","author":"Risser","year":"2009","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.biopha.2025.117969_bib4","series-title":"WHO Analgesic Ladder","author":"Anekar","year":"2024"},{"key":"10.1016\/j.biopha.2025.117969_bib5","unstructured":"Steinhilber, D.; Schubert-Zsilavecz, M.; Roth, H. Medizinische Chemie. 2010."},{"key":"10.1016\/j.biopha.2025.117969_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/B978-0-444-64074-1.00054-9","article-title":"Antipyretic therapy: clinical pharmacology","volume":"157","author":"Lee","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.biopha.2025.117969_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0002-9343(01)00834-8","article-title":"Antipyretics: mechanisms of action and clinical use in fever suppression","volume":"111","author":"Aronoff","year":"2001","journal-title":"Am. J. Med"},{"key":"10.1016\/j.biopha.2025.117969_bib8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/bega.2001.0236","article-title":"COX-1 and COX-2 inhibitors","volume":"15","author":"Hawkey","year":"2001","journal-title":"Best. Pr. Res Clin. Gastroenterol."},{"issue":"50","key":"10.1016\/j.biopha.2025.117969_bib9","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: structural and functional insights","author":"Rouzer","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2025.117969_bib10","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/S0002-9343(99)00114-X","article-title":"Effects of nonsteroidal anti-inflammatory therapy on platelets","volume":"106","author":"Schafer","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.biopha.2025.117969_bib11","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.117969_bib12","first-page":"15","article-title":"COX-1 and COX-2 tissue expression: implications and predictions","volume":"49","author":"Crofford","year":"1997","journal-title":"J. Rheuma Suppl."},{"key":"10.1016\/j.biopha.2025.117969_bib13","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2025.117969_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.117.09906","article-title":"Cyclooxygenase-2 selectively controls renal blood flow through a novel PPARbeta\/delta-dependent vasodilator pathway","volume":"71","author":"Kirkby","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2025.117969_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/j.1552-4604.1995.tb04050.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis","volume":"35","author":"Schafer","year":"1995","journal-title":"J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.117969_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-114-9-735","article-title":"Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs","volume":"114","author":"Piper","year":"1991","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.biopha.2025.117969_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086806","article-title":"Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro models","volume":"9","author":"Novakova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.117969_bib18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11095-006-9905-5","article-title":"Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin","volume":"23","author":"Parepally","year":"2006","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.117969_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.117969_bib20","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/S0002-9343(99)00113-8","article-title":"Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications","volume":"106","author":"Whelton","year":"1999","journal-title":"Am. J. Med"},{"key":"10.1016\/j.biopha.2025.117969_bib21","unstructured":"Rote Liste; 63. Ausgabe 2023, 63. Ausgabe ed.; Rote Liste Service GmbH: Frankfurt\/Main, 2023."},{"key":"10.1016\/j.biopha.2025.117969_bib22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","article-title":"Use of ibuprofen and risk of Parkinson disease","volume":"76","author":"Gao","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117969_bib23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1080\/10717544.2021.1937383","article-title":"Repurposing ibuprofen-loaded microemulsion for the management of Alzheimer's disease: evidence of potential intranasal brain targeting","volume":"28","author":"Wen","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2025.117969_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","article-title":"Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis","volume":"74","author":"Gagne","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117969_bib25","first-page":"478","article-title":"Inflammation in Parkinson's disease: an update","volume":"9","author":"Smith","year":"2008","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.biopha.2025.117969_bib26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","article-title":"Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease","volume":"29","author":"Dhapola","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2025.117969_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer's Disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2025.117969_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-4347(94)00038-7","article-title":"Changes in the liver, kidney and heart fatty acid composition following administration of ibuprofen to mice","volume":"656","author":"Tvrzicka","year":"1994","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.biopha.2025.117969_bib29","first-page":"450","article-title":"The effect of ibuprofen on the composition of tissue lipids in an experiment]","volume":"134","author":"Tvrzicka","year":"1995","journal-title":"Cas. Lek. Cesk"},{"key":"10.1016\/j.biopha.2025.117969_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/107999003321532493","article-title":"Inflammatory liver steatosis caused by IL-12 and IL-18","volume":"23","author":"Kaneda","year":"2003","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1016\/j.biopha.2025.117969_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1007649815992","article-title":"Hepatotoxicity due to mitochondrial dysfunction","volume":"15","author":"Pessayre","year":"1999","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.biopha.2025.117969_bib32","first-page":"92","article-title":"Nonalcoholic Fatty liver disease from the perspective of an internist","volume":"4","author":"Nair","year":"2002","journal-title":"Ochsner J."},{"key":"10.1016\/j.biopha.2025.117969_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/alzrt103","article-title":"Lipidomics of Alzheimer's disease: current status","volume":"4","author":"Wood","year":"2012","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.biopha.2025.117969_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-8993(95)00931-F","article-title":"Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain","volume":"698","author":"Ginsberg","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2025.117969_bib35","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1471-4159.2001.00332.x","article-title":"Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry","volume":"77","author":"Han","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.117969_bib36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","article-title":"Deregulation of sphingolipid metabolism in Alzheimer's disease","volume":"31","author":"He","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2025.117969_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94706-3","article-title":"Shotgun lipidomics of liver and brain tissue of Alzheimer's disease model mice treated with acitretin","volume":"11","author":"Lauer","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117969_bib38","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117969_bib39","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s11033-020-05305-w","article-title":"Inhibitory effects of curcumin on H(2)O(2)-induced cell damage and APP expression and processing in SH-SY5Y cells transfected with APP gene with Swedish mutation","volume":"47","author":"Song","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2025.117969_bib40","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s12010-017-2468-6","volume":"183","author":"Pahrudin Arrozi","year":"2017","journal-title":"Appl. Biochem Biotechnol."},{"key":"10.1016\/j.biopha.2025.117969_bib41","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.neuroscience.2010.04.019","article-title":"L-theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway","volume":"168","author":"Di","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2025.117969_bib42","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1042\/BST0331146","article-title":"The contributions of biosynthesis and acyl chain remodelling to the molecular species profile of phosphatidylcholine in yeast","volume":"33","author":"Boumann","year":"2005","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.biopha.2025.117969_bib43","first-page":"84","article-title":"Effect of cholesterol on the structure and dynamic properties of unsaturated phospholipid bilayers]","volume":"53","author":"Kornilov","year":"2008","journal-title":"Biofizika"},{"key":"10.1016\/j.biopha.2025.117969_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(00)00128-6","article-title":"Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders","volume":"106","author":"Farooqui","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biopha.2025.117969_bib45","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/ijms16010924","article-title":"Lipid metabolism, apoptosis and cancer therapy","volume":"16","author":"Huang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117969_bib46","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.devcel.2013.01.013","article-title":"Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets","volume":"24","author":"Wilfling","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biopha.2025.117969_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0163-7827(85)90011-6","article-title":"Lipids of nervous tissue: composition and metabolism","volume":"24","author":"Sastry","year":"1985","journal-title":"Prog. Lipid Res"},{"key":"10.1016\/j.biopha.2025.117969_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainresbull.2022.11.005","article-title":"Plasmalogens inhibit neuroinflammation and promote cognitive function","volume":"192","author":"Hossain","year":"2023","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2025.117969_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117969_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/BC20060051","article-title":"Lipid rafts in health and disease","volume":"99","author":"Michel","year":"2007","journal-title":"Biol. Cell"},{"key":"10.1016\/j.biopha.2025.117969_bib51","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI0216390","article-title":"Cholesterol, lipid rafts, and disease","volume":"110","author":"Simons","year":"2002","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.117969_bib52","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.bbalip.2017.06.010","article-title":"How lipid droplets \"TAG\" along: glycerolipid synthetic enzymes and lipid storage","volume":"1862","author":"Wang","year":"2017","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2025.117969_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1152\/advan.00094.2009","article-title":"Insights into digestion and absorption of major nutrients in humans","volume":"34","author":"Goodman","year":"2010","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.biopha.2025.117969_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030474","article-title":"Lipid metabolism in oncology: why it matters, how to research, and how to treat","volume":"13","author":"Matsushita","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.117969_bib55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/138945009787846443","article-title":"Triacylglycerol metabolism","volume":"10","author":"Karantonis","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2025.117969_bib56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-4159.2004.02743.x","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action","volume":"91","author":"Gasparini","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.117969_bib57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/0269881108097630","article-title":"Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model","volume":"24","author":"Van Dam","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.117969_bib58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuroscience.2014.03.048","article-title":"Ibuprofen partially attenuates neurodegenerative symptoms in presenilin conditional double-knockout mice","volume":"270","author":"Dong","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2025.117969_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2008.01.095","article-title":"Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice","volume":"1207","author":"McKee","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.biopha.2025.117969_bib60","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10654-007-9199-x","article-title":"The Rotterdam Study: objectives and design update","volume":"22","author":"Hofman","year":"2007","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.biopha.2025.117969_bib61","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease","volume":"345","author":"in t\u2032 Veld","year":"2001","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.117969_bib62","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117969_bib63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF03325217","article-title":"A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease","volume":"21","author":"Pasqualetti","year":"2009","journal-title":"Aging Clin. Exp. Res"},{"key":"10.1016\/j.biopha.2025.117969_bib64","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial","volume":"289","author":"Aisen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.117969_bib65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"Rofecoxib Protocol 091 Study, G. Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","volume":"62","author":"Reines","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117969_bib66","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1212\/WNL.43.8.1609","article-title":"Clinical trial of indomethacin in Alzheimer's disease","volume":"43","author":"Rogers","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117969_bib67","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","article-title":"NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies","volume":"28","author":"McGeer","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2025.117969_bib68","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.celrep.2020.02.025","article-title":"beta-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia","volume":"30","author":"Friker","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2025.117969_bib69","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease","volume":"20","author":"Lim","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.117969_bib70","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00005072-199907000-00008","article-title":"Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease","volume":"58","author":"Guan","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.biopha.2025.117969_bib71","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.addr.2019.12.003","article-title":"Sphingolipids in Alzheimer's disease, how can we target them?","volume":"159","author":"Crivelli","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.117969_bib72","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fphys.2020.00598","article-title":"Involvement of lipids in Alzheimer's disease pathology and potential therapies","volume":"11","author":"Chew","year":"2020","journal-title":"Front Physiol."},{"key":"10.1016\/j.biopha.2025.117969_bib73","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12035-019-01733-3","article-title":"Lipid analysis of the 6-Hydroxydopamine-treated SH-SY5Y Cell Model for Parkinson's disease","volume":"57","author":"Xicoy","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.117969_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70014","article-title":"Direct current stimulation (DCS) modulates lipid metabolism and intercellular vesicular trafficking in SHSY-5Y Cell Line: implications for Parkinson's disease","volume":"169","author":"Piccoli","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.117969_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/nu15061467","article-title":"Aspartame and its metabolites cause oxidative stress and mitochondrial and lipid alterations in SH-SY5Y Cells","volume":"15","author":"Griebsch","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.117969_bib76","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1007\/s00216-021-03819-1","article-title":"Study of the potential neuroprotective effect of Dunaliella salina extract in SH-SY5Y cell model","volume":"414","author":"Gallego","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.biopha.2025.117969_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.769218","article-title":"In vitro neuroprotective potential and lipidomics study of olive leaves extracts enriched in triterpenoids","volume":"8","author":"Gallego","year":"2021","journal-title":"Front Nutr."},{"key":"10.1016\/j.biopha.2025.117969_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032972","article-title":"Gemfibrozil-induced intracellular triglyceride increase in SH-SY5Y, HEK and Calu-3 Cells","volume":"24","author":"Bachmann","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117969_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162574","article-title":"Vitamin B12 attenuates changes in phospholipid levels related to oxidative stress in SH-SY5Y cells","volume":"11","author":"Theiss","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.117969_bib80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2017.06.006","article-title":"Lipidomics in translational research and the clinical significance of lipid-based biomarkers","volume":"189","author":"Stephenson","year":"2017","journal-title":"Transl. Res"},{"key":"10.1016\/j.biopha.2025.117969_bib81","article-title":"Phosphatidylcholine enhances homeostasis in peach seedling cell membrane and increases its salt stress tolerance by phosphatidic acid","volume":"23","author":"Sun","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117969_bib82","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/09687688.2015.1066894","article-title":"Phosphatidylcholine's functions beyond that of a membrane brick","volume":"32","author":"Furse","year":"2015","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.biopha.2025.117969_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02361-5","article-title":"Phosphatidylcholine restores neuronal plasticity of neural stem cells under inflammatory stress","volume":"11","author":"Magaquian","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117969_bib84","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41598-017-18700-4","article-title":"Specific phospholipids regulate the acquisition of neuronal and astroglial identities in post-mitotic cells","volume":"8","author":"Montaner","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117969_bib85","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/ijms14011310","article-title":"Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers","volume":"14","author":"Kosicek","year":"2013","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117969_bib86","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117969_bib87","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ceb.2019.03.018","article-title":"Lipid droplet biogenesis","volume":"59","author":"Jackson","year":"2019","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117969_bib88","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3389\/fnins.2020.00742","article-title":"Lipid droplets in neurodegenerative disorders","volume":"14","author":"Farmer","year":"2020","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2025.117969_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010027","article-title":"The role of lipids in Parkinson's disease","volume":"8","author":"Xicoy","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.117969_bib90","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/00325481.1991.11700928","article-title":"Nonprescription drugs and hypertension. Which ones affect blood pressure?","volume":"89","author":"Bradley","year":"1991","journal-title":"Post. Med"},{"key":"10.1016\/j.biopha.2025.117969_bib91","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-2012-120370","article-title":"Sporadic Alzheimer's disease: the starving brain","volume":"31","author":"Mamelak","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.117969_bib92","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.plipres.2019.04.003","article-title":"Plasmalogens: a potential therapeutic target for neurodegenerative and cardiometabolic disease","volume":"74","author":"Paul","year":"2019","journal-title":"Prog. Lipid Res"},{"key":"10.1016\/j.biopha.2025.117969_bib93","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","article-title":"Functions of plasmalogen lipids in health and disease","volume":"1822","author":"Braverman","year":"2012","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2025.117969_bib94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1749-6632.2012.06641.x","article-title":"Effects of plasmalogens on systemic lipopolysaccharide-induced glial activation and beta-amyloid accumulation in adult mice","volume":"1262","author":"Katafuchi","year":"2012","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"Pt 3","key":"10.1016\/j.biopha.2025.117969_bib95","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1042\/bj3380769","article-title":"Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether","volume":"338","author":"Zoeller","year":"1999","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2025.117969_bib96","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2174\/092986709788682164","article-title":"Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis","volume":"16","author":"Lessig","year":"2009","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.biopha.2025.117969_bib97","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12944-019-1044-1","article-title":"Plasmalogens and Alzheimer's disease: a review","volume":"18","author":"Su","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2025.117969_bib98","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"Tonnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.117969_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117969_bib100","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/BF00992508","article-title":"Neural membrane phospholipids in Alzheimer disease","volume":"20","author":"Wells","year":"1995","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.biopha.2025.117969_bib101","first-page":"524","article-title":"Plasmalogen deficiency and neuropathology in Alzheimer's disease: causation or coincidence?","volume":"5","author":"Senanayake","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopha.2025.117969_bib102","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adh Migr."},{"key":"10.1016\/j.biopha.2025.117969_bib103","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer's disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.biopha.2025.117969_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186592","article-title":"Cannabidiol-mediated changes to the phospholipid profile of UVB-irradiated keratinocytes from psoriatic patients","volume":"21","author":"Luczaj","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117969_bib105","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20132451","article-title":"Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease","volume":"211","author":"Lee","year":"2014","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2025.117969_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111610","article-title":"Physiological functions and therapeutic applications of neutral sphingomyelinase and acid sphingomyelinase","volume":"139","author":"Xiang","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.117969_bib107","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/oxfordjournals.bmb.a011629","article-title":"Ceramide signaling in apoptosis","volume":"53","author":"Haimovitz-Friedman","year":"1997","journal-title":"Br. Med Bull."},{"key":"10.1016\/j.biopha.2025.117969_bib108","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000535131","article-title":"Brain lipids and lipid droplet dysregulation in Alzheimer's disease and neuropsychiatric disorders","volume":"9","author":"Zhao","year":"2023","journal-title":"Complex Psychiatry"},{"key":"10.1016\/j.biopha.2025.117969_bib109","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","article-title":"The glia-neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in glia via APOE\/D","volume":"26","author":"Liu","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.117969_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106741","article-title":"ANGPTL4-mediated microglial lipid droplet accumulation: bridging Alzheimer's disease and obesity","volume":"203","author":"Li","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2025.117969_bib111","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","article-title":"Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease","volume":"35","author":"Whiley","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2025.117969_bib112","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3233\/JAD-230061","article-title":"Accelerated breakdown of phosphatidylcholine and phosphatidylethanolamine is a predominant brain metabolic defect in Alzheimer's disease","volume":"93","author":"Blusztajn","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.117969_bib113","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ajcn\/nqz148","article-title":"Associations of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic Heart Disease Risk Factor Study","volume":"110","author":"Ylilauri","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2025.117969_bib114","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archneur.63.11.1545","article-title":"Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study","volume":"63","author":"Schaefer","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2025.117969_bib115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ebiom.2017.02.012","article-title":"Efficacy and blood plasmalogen changes by oral administration of plasmalogen in patients with mild Alzheimer's disease and mild cognitive impairment: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"17","author":"Fujino","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2025.117969_bib116","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1083\/jcb.200307017","article-title":"Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway","volume":"164","author":"Lee","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117969_bib117","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neurobiolaging.2016.04.008","article-title":"Peripheral sphingolipids are associated with variation in white matter microstructure in older adults","volume":"43","author":"Gonzalez","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2025.117969_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091311","article-title":"The multiple roles of sphingomyelin in Parkinson's disease","volume":"11","author":"Signorelli","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2025.117969_bib119","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1212\/WNL.0000000000004749","article-title":"Increased midlife triglycerides predict brain beta-amyloid and tau pathology 20 years later","volume":"90","author":"Nagga","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117969_bib120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.stem.2015.08.001","article-title":"Aberrant lipid metabolism in the forebrain niche suppresses adult neural stem cell proliferation in an animal model of Alzheimer's disease","volume":"17","author":"Hamilton","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biopha.2025.117969_bib121","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer's disease microglia","volume":"628","author":"Haney","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117969_bib122","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/jcph.307","article-title":"Plasma and cerebrospinal fluid concentrations of ibuprofen in pediatric patients and antipyretic effect: pharmacokinetic-pharmacodynamic modeling analysis","volume":"54","author":"Har-Even","year":"2014","journal-title":"J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.117969_bib123","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejps.2004.10.004","article-title":"Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases","volume":"24","author":"Mannila","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.117969_bib124","article-title":"Analysis of cell viability by the lactate dehydrogenase assay","volume":"2018","author":"Kumar","year":"2018","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.biopha.2025.117969_bib125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.biopha.2025.117969_bib126","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1016\/j.chroma.2011.07.073","article-title":"From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry","volume":"1218","author":"Grimm","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.biopha.2025.117969_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042295","article-title":"Methylxanthines induce a change in the AD\/neurodegeneration-linked lipid profile in neuroblastoma cells","volume":"23","author":"Janitschke","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117969_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415535","article-title":"The influence of acitretin on brain lipidomics in adolescent mice-implications for pediatric and adolescent dermatological therapy","volume":"23","author":"Lauer","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:51:01Z","timestamp":1762311061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":128,"alternative-id":["S0753332225001635"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117969","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of Ibuprofen on glycerophospholipids and sphingolipids in context of Alzheimer\u00b4s Disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117969"}}